Elanco Animal Health Reports Third Quarter 2026 Results
Elanco Animal Health Inc ELAN
News
October Consumer Research Confirms Pet Health Remains Non-Negotiable Household Priority
Elanco to Participate in UBS Global Healthcare Conference
Caring for Both Ends of the Leash: Elanco and The Veterinary Cooperative Support The Street Dog Coalition
Addressing Critical Health Needs Through Innovation
Elanco Animal Health Appoints Jamie Preston as Chief People Officer
Transparency, Connection, The Future of Care with Dr. Molly Brinkmann, @DrMollySays
More Than 2 Million Dogs Reach for Zen: Elanco Helps Veterinarians and Pet Owners Navigate Extended Allergy Season With Zenrelia(TM) (Ilunocitinib Tablets)
One Health Innovation District Breaks Ground on One Health Research Institute, Anchored by Purdue University and Elanco Animal Health
Elanco to Participate in BofA Securities Global Healthcare Conference 2026
Expanding Tick and Itch Season Supports Momentum in Elanco Innovation, Meeting Pet Owner Demand for Health and Wellness Care
Expanding Tick and Itch Season Supports Momentum in Elanco Innovation, Meeting Pet Owner Demand for Health and Wellness Care
Elanco Confirms Date and Conference Call for Third Quarter 2026 Financial Results Announcement
Elanco to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
Elanco Scales Biologics Capabilities With Expansion of Kansas Manufacturing Facility
Elanco Scales Biologics Capabilities with Expansion of Kansas Manufacturing Facility
Elanco Animal Health Receives Emergency FDA Approval for Screwworm Prevention Spray
Elanco Animal Health Gets FDA, EPA Emergency Authorizations for Screwworm Treatments
Elanco Animal Health Gets USDA Approval for Canine-Dermatitis Treatment
Elanco Animal Health Obtains FDA Authorization for Screwworm Treatment
United States